Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Is Poised to Shatter These 2 Records in 2022
Pfizer Is Poised to Shatter These 2 Records in 2022
Pfizer Is Poised to Shatter These 2 Records in 2022
Submitted by
admin
on May 5, 2022 - 10:41am
Source:
Motley Fool
News Tags:
Pfizer
earnings
Paxlovid
Headline:
Pfizer Is Poised to Shatter These 2 Records in 2022
snippet:
Pfizer's Paxlovid appears to be on track to become the best-selling non-vaccine drug ever.
Pfizer seems likely to generate the most annual revenue ever for a pharma company.
However, 2022 could be Pfizer's peak.
Do Not Allow Advertisers to Use My Personal information